MENU
+Compare
GILD
Stock ticker: NASDAQ
AS OF
Sep 9 closing price
Price
$115.76
Change
-$0.12 (-0.10%)
Capitalization
143.64B

GILD Gilead Sciences Forecast, Technical & Fundamental Analysis

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GILD with price predictions
Sep 09, 2025

GILD in upward trend: price rose above 50-day moving average on September 05, 2025

GILD moved above its 50-day moving average on September 05, 2025 date and that indicates a change from a downward trend to an upward trend. In of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 08, 2025. You may want to consider a long position or call options on GILD as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 285 cases where GILD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for GILD turned negative on August 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GILD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GILD broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.299) is normal, around the industry mean (9.528). P/E Ratio (22.968) is within average values for comparable stocks, (24.020). Projected Growth (PEG Ratio) (0.218) is also within normal values, averaging (1.780). Dividend Yield (0.027) settles around the average of (0.028) among similar stocks. P/S Ratio (5.053) is also within normal values, averaging (3.458).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GILD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GILD is expected to report earnings to rise 7.46% to $2.16 per share on October 23

Gilead Sciences GILD Stock Earnings Reports
Q3'25
Est.
$2.16
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.51
The last earnings report on August 07 showed earnings per share of $2.01, beating the estimate of $1.96. With 6.22M shares outstanding, the current market capitalization sits at 143.64B.
A.I.Advisor
published Dividends

GILD is expected to pay dividends on September 29, 2025

Gilead Sciences GILD Stock Dividends
A dividend of $0.79 per share will be paid with a record date of September 29, 2025, and an ex-dividend date of September 15, 2025. The last dividend of $0.79 was paid on June 27. Read more...
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NFLY17.410.22
+1.28%
YieldMax NFLX Option Income Strategy ETF
GMNY49.500.07
+0.15%
Goldman Sachs Dynamic New Yor Mun IncETF
ITDB32.580.01
+0.02%
iShares LifePath Target Date 2030 ETF
PDT13.42-0.01
-0.07%
John Hancock Premium Dividend Fund
SPSM45.94-0.41
-0.88%
SPDR® Portfolio S&P 600™ Sm Cap ETF

GILD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with BMY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-0.10%
BMY - GILD
47%
Loosely correlated
+1.09%
GSK - GILD
43%
Loosely correlated
+1.82%
NVS - GILD
40%
Loosely correlated
-0.51%
AMGN - GILD
40%
Loosely correlated
-0.08%
PFE - GILD
38%
Loosely correlated
+0.65%
More